Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients.

MLA

Elkhazraji, Abdelhak, et al. “Effect of CYP2C9, VKORC1, CYP4F2, and GGCX Gene Variants and Patient Characteristics on Acenocoumarol Maintenance Dose: Proposal for a Dosing Algorithm for Moroccan Patients.” Drug Discoveries & Therapeutics, vol. 12, no. 2, Jan. 2018, pp. 68–76. EBSCOhost, https://doi.org/10.5582/ddt.2017.01063.

APA

Elkhazraji, A., Bouaiti, E. A., Boulahyaoui, H., Nahmtchougli, C. P., Zahid, H., Bensaid, M., Ibrahimi, A., & Messaoudi, N. (2018). Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients. Drug Discoveries & Therapeutics, 12(2), 68–76. https://doi.org/10.5582/ddt.2017.01063

Chicago

Elkhazraji, Abdelhak, El Arbi Bouaiti, Hassan Boulahyaoui, Christiana Philippa Nahmtchougli, Hafid Zahid, Mounia Bensaid, Azeddine Ibrahimi, and Nezha Messaoudi. 2018. “Effect of CYP2C9, VKORC1, CYP4F2, and GGCX Gene Variants and Patient Characteristics on Acenocoumarol Maintenance Dose: Proposal for a Dosing Algorithm for Moroccan Patients.” Drug Discoveries & Therapeutics 12 (2): 68–76. doi:10.5582/ddt.2017.01063.